KPL Licenses Expression Pathology s Protein-Extraction Tech for Use in Upcoming Products | GenomeWeb

NEW YORK, July 21 (GenomeWeb News) - As part of a license-and-supply agreement, Kirkegaard and Perry Laboratories (KPL) has gained exclusive rights to market protein immunodetection products based on Expression Pathology's Liquid Tissue technology in the life-science research market, the companies said today in a statement.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: gene flow between ancient chimpanzees and bonobos, and more.

A startup wants to match customers to wine based on their DNA and one critic calls the idea 'silly,' Stat News reports.

Researchers trace the origins of brown rats using genetic analysis to China, the New York Times reports.

In Nature this week: genetic history of HIV in the US, and more.